Prince Pharmaceutical Co., Ltd. (TPEX:6935)
29.00
0.00 (0.00%)
Apr 29, 2026, 1:45 PM CST
Prince Pharmaceutical Revenue
In the year 2025, Prince Pharmaceutical had annual revenue of 1.06B TWD with 53.07% growth. Prince Pharmaceutical had revenue of 608.14M in the half year ending December 31, 2025, with 53.06% growth.
Revenue
1.06B
Revenue Growth
+53.07%
P/S Ratio
1.01
Revenue / Employee
4.89M
Employees
216
Market Cap
1.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anxo Pharmaceutical | 883.22M |
| Original BioMedicals | 381.00K |
| Mediera | 229.85M |
| Excelsior Biopharma | 898.26M |
| DV Biomed | 794.18M |
| Winston Medical Supply | 700.07M |
| GeneFerm Biotechnology | 677.10M |
| InnoPharmax | 68.99M |